Cytosorbents Corp SEC filings CTSO

Cytosorbents Corp has 977 filings in SEC EDGAR's recent list, going back to Mar 29, 2004. Its latest annual report, Form ARS, was filed on Jun 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Cytosorbents Corp SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2026 Sep 22, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
4 Insider transaction Sep 9, 2026 Sep 4, 2026
8-K Current report
Bylaw or fiscal year change
Sep 8, 2026 Sep 8, 2026
8-K Current report
Shareholder vote results
Aug 14, 2026 Aug 13, 2026
8-K Current report
Regulation FD disclosure
Aug 7, 2026 Aug 6, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Listing notice
Jul 6, 2026 Jun 29, 2026
ARS Annual report to shareholders Jun 25, 2026 Dec 31, 2025
DEFA14A Additional proxy material Jun 25, 2026 —
DEF 14A Proxy statement Jun 25, 2026 Aug 13, 2026
8-K Current report
Regulation FD disclosure
Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
4 Insider transaction Jun 15, 2026 Jun 12, 2026
PRE 14A Preliminary proxy statement Jun 11, 2026 Jun 11, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
10-K/A Amended annual report Apr 15, 2026 Dec 31, 2025
8-K Current report
Listing notice
Apr 2, 2026 Apr 1, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 25, 2026 Mar 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Nov 20, 2025 Nov 18, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Listing notice
Oct 3, 2025 Oct 2, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 16, 2025 Sep 16, 2025
8-K Current report
Other events
Aug 20, 2025 Aug 14, 2025
144 Notice of proposed sale Aug 19, 2025 —
4 Insider transaction Aug 8, 2025 Aug 8, 2025
4 Insider transaction Aug 8, 2025 Aug 8, 2025
4 Insider transaction Aug 8, 2025 Aug 8, 2025
4 Insider transaction Aug 8, 2025 Aug 8, 2025
4 Insider transaction Aug 8, 2025 Aug 8, 2025
4 Insider transaction Aug 8, 2025 Aug 8, 2025
4 Insider transaction Aug 8, 2025 Aug 8, 2025
4 Insider transaction Aug 8, 2025 Aug 8, 2025
8-K Current report
Acquisition or sale of assets
Aug 7, 2025 Aug 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Other events
Aug 1, 2025 Jul 31, 2025
8-K Current report
Other events
Jul 2, 2025 Jul 2, 2025
8-K Current report
Other events
Jun 24, 2025 Jun 24, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 12, 2025
8-K Current report
Regulation FD disclosure
Jun 11, 2025 Jun 10, 2025
SCHEDULE 13G Ownership over 5% (passive) May 28, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
8-K Current report
Other events
May 1, 2025 Apr 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 12, 2025
8-K Current report
Regulation FD disclosure
Apr 17, 2025 Apr 17, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 17, 2025 —
8-K Current report
Regulation FD disclosure
Apr 15, 2025 Apr 14, 2025
8-K Current report
Other events
Apr 4, 2025 Apr 4, 2025
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Restatement
Mar 31, 2025 Mar 25, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 21, 2025 Mar 21, 2025
4 Insider transaction Mar 4, 2025 Feb 24, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 4, 2025 Mar 4, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
4 Insider transaction Feb 26, 2025 Feb 24, 2025
8-K Current report
Regulation FD disclosure
Feb 25, 2025 Feb 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 31, 2025 —
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 17, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 7, 2025 —
8-K Current report
Other events
Jan 6, 2025 Jan 6, 2025
8-K Current report
Results of operations
Jan 3, 2025 Jan 3, 2025
8-K Current report
Regulation FD disclosure
Dec 23, 2024 Dec 23, 2024
4 Insider transaction Dec 16, 2024 Dec 13, 2024
4 Insider transaction Dec 13, 2024 Dec 11, 2024
FWP Free writing prospectus Dec 9, 2024 —
424B5 Prospectus supplement Dec 9, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 9, 2024 Dec 9, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
8-K Current report
Other events
Oct 1, 2024 Oct 1, 2024
424B5 Prospectus supplement Oct 1, 2024 —
8-K Current report
Results of operations, Other events
Oct 1, 2024 Oct 1, 2024
EFFECT Filing Sep 30, 2024 —
CORRESP Letter to the SEC Sep 27, 2024 —
S-3/A Form s-3/a Sep 26, 2024 —
8-K Current report
Material agreement
Aug 20, 2024 Aug 16, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
3 Initial insider ownership Aug 16, 2024 Aug 14, 2024
S-8 Employee stock plan registration Aug 16, 2024 —
8-K Current report
Officer or director change
Aug 16, 2024 Aug 13, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 13, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Other events
Aug 1, 2024 Jul 26, 2024
UPLOAD Letter from the SEC Jul 31, 2024 —
S-3 Shelf registration Jul 26, 2024 —
424B5 Prospectus supplement Jul 26, 2024 —
8-K Current report
Material agreement, Other events
Jul 5, 2024 Jun 28, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 6, 2024
8-K Current report
Listing notice
May 22, 2024 May 20, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Bylaw or fiscal year change
May 6, 2024 May 2, 2024
ARS Annual report to shareholders Apr 19, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 19, 2024 —
DEF 14A Proxy statement Apr 19, 2024 Jun 6, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
8-K Current report
Officer or director change
Apr 3, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 23, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
4 Insider transaction Apr 2, 2024 Mar 29, 2024
8-K Current report
Results of operations
Mar 15, 2024 Mar 14, 2024
10-K Annual report Mar 15, 2024 Dec 31, 2023
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
8-K Current report
Listing notice, Other events
Jan 17, 2024 Jan 17, 2024
SC 13G Ownership over 5% (passive) Jan 8, 2024 —
8-K Current report
Other events
Dec 28, 2023 Dec 28, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
4 Insider transaction Dec 15, 2023 Dec 13, 2023
8-K Current report
Other events
Dec 13, 2023 Dec 13, 2023
424B5 Prospectus supplement Dec 11, 2023 —
8-K Current report
Material agreement, Other events
Dec 11, 2023 Dec 11, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Other events
Sep 27, 2023 Sep 27, 2023
4 Insider transaction Sep 20, 2023 Sep 18, 2023
8-K Current report
Material agreement, Officer or director change
Sep 19, 2023 Sep 18, 2023
8-K Current report
Other events
Sep 12, 2023 Sep 11, 2023
8-K Current report
Officer or director change
Sep 1, 2023 Aug 28, 2023
3 Initial insider ownership Aug 15, 2023 Aug 7, 2023
8-K Current report
Regulation FD disclosure
Aug 11, 2023 Aug 11, 2023
4 Insider transaction Aug 8, 2023 Aug 4, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 1, 2023
10-Q Quarterly report Aug 1, 2023 Jun 30, 2023
8-K Current report
Material agreement, Officer or director change
Jul 19, 2023 Jul 19, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
4 Insider transaction Jul 11, 2023 Jul 7, 2023
8-K Current report
Officer or director change
Jul 11, 2023 Jul 7, 2023
8-K Current report
Other events
Jul 7, 2023 Jul 7, 2023
8-K Current report
Shareholder vote results
Jun 7, 2023 Jun 6, 2023
4 Insider transaction May 30, 2023 May 25, 2023
4 Insider transaction May 12, 2023 May 10, 2023
8-K Current report
Results of operations
May 2, 2023 May 2, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
8-K Current report
Other events
Apr 26, 2023 Apr 20, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 21, 2023 —
DEF 14A Proxy statement Apr 21, 2023 Jun 6, 2023
8-K Current report
Officer or director change
Apr 20, 2023 Apr 17, 2023
8-K Current report
Material agreement, Officer or director change
Apr 6, 2023 Mar 31, 2023
4 Insider transaction Apr 5, 2023 Apr 4, 2023
4 Insider transaction Apr 5, 2023 Apr 3, 2023
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
10-K Annual report Mar 9, 2023 Dec 31, 2022
4 Insider transaction Mar 1, 2023 Feb 27, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
4 Insider transaction Feb 8, 2023 Feb 6, 2023
SC 13G Ownership over 5% (passive) Feb 7, 2023 —
8-K Current report
Results of operations, Other events
Feb 1, 2023 Jan 31, 2023
8-K Current report
Material agreement, Other events
Dec 29, 2022 Dec 28, 2022
4 Insider transaction Dec 9, 2022 Dec 8, 2022
4 Insider transaction Dec 8, 2022 Dec 6, 2022
8-K Current report
Other events
Nov 16, 2022 Nov 14, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
CTSO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Princeton, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1175151
Former names
MedaSorb Technologies CORP (until Apr 15, 2010); GILDER ENTERPRISES INC (until Jul 24, 2006)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.